How to Source Montelukast + Levocetirizine for Pharmaceutical Formulation
Montelukast + Levocetirizine (Tablet, Montelukast (10 mg) + Levocetirizine (5 mg)) is classified under Allergy Medication. It is therapeutically aligned with reference brands such as Levocet-M, Montel-LC, Combizar(EU). This guide highlights key sourcing factors buyers should consider when procuring high-quality Montelukast + Levocetirizine for formulation, R&D, or bulk manufacturing.
Product Overview:
Montelukast 10 mg + Levocetirizine 5 mg tablets provide effective relief from allergic rhinitis and urticaria, combining antihistamine and anti-inflammatory action. Marketed as Montel-LC, Levocet-M, and generics, it's ideal for EU and US pharma markets.
Montelukast Sodium 10 mg and Levocetirizine Hydrochloride 5 mg tablets offer dual-action relief from...
Montelukast + Levocetirizine API – ideal for compliant pharmaceutical formulation.
Quick Insight: Over 60% of formulation delays are linked to poor API sourcing. A well-planned sourcing strategy can reduce risk and accelerate market entry.
1. Regulatory Compliance & Documentation
Ensure suppliers provide:
- ✔ Valid DMF (Drug Master File)
- ✔ COA (Certificate of Analysis) for each batch
- ✔ GMP, ISO, or ICH Q7 compliance certificates
2. Purity, Grade & Specification Matching
Montelukast + Levocetirizine must meet exact grade and purity for your dosage form:
- ✔ USP / EP / JP grade verification
- ✔ Particle size distribution check
- ✔ Residual solvent and heavy metal limits
3. Supplier Reliability & Audit History
- ✔ Positive past audit reports
- ✔ Pharma client references
- ✔ Years of proven API manufacturing experience
4. Commercial Terms: Pricing, MOQ & Flexibility
- ✔ Transparent pricing
- ✔ Pilot batch MOQ flexibility
- ✔ Volume-based discounts
5. Lead Time, Inventory & Logistics
Typical lead time for Montelukast + Levocetirizine is 4–6 weeks.
- ✔ Emergency dispatch options
- ✔ Regional warehousing
- ✔ Special storage if needed
6. Formulation Support
- ✔ Technical datasheets
- ✔ Sample availability
- ✔ Stability study support
Pro Tip: Engage supplier formulation experts early — it can improve bioavailability and cut development time.
Conclusion
Sourcing Montelukast + Levocetirizine is more than procurement—it’s a strategic partnership. With its tablet form and Montelukast (10 mg) + Levocetirizine (5 mg) specification, choosing a compliant supplier ensures consistent quality and regulatory approval. Prioritize documentation, verify compatibility, and build relationships with transparent, reliable suppliers to secure long-term success.
Next Step: Get expert assistance in sourcing Montelukast + Levocetirizine.
Request a Quote
Frequently Asked Questions For Sourcing of Montelukast + Levocetirizine
What is the typical lead time for Montelukast + Levocetirizine?
Lead times range from 4–6 weeks depending on supplier and region.
Is Montelukast + Levocetirizine available in multiple grades?
Yes — common grades include USP, EP, and JP. Verify grade suitability for your dosage form before purchase.
Does Montelukast + Levocetirizine require special storage?
It should be stored in a cool, dry place away from direct sunlight.
Is a Drug Master File (DMF) available for Montelukast + Levocetirizine?
Yes, a DMF is available for regulated markets upon request. It includes detailed quality, manufacturing, and stability data.
Can I request samples or a pilot batch of Montelukast + Levocetirizine?
Yes — pilot batches or samples can be arranged for R&D, stability studies, or formulation trials. MOQ may vary based on region and regulatory scope.
What compliance certificates are available for Montelukast + Levocetirizine?
Available documentation may include GMP, ISO 9001, ISO 14001, and ICH Q7 certificates, along with CoA, TDS, and stability data.
Is Montelukast + Levocetirizine suitable for regulated markets like US/EU?
Yes — compliant with EU/US/WHO GMP standards and available with regulatory support documentation for filings.
Can Montelukast + Levocetirizine be used in fixed-dose combinations?
Yes — many formulations support inclusion in FDCs. Compatibility studies and formulation consultation are available on request.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our
Privacy Policy.